Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The mechanism by which the conformationally altered inhibito...

Class:IdSummation:143360
_displayNameThe mechanism by which the conformationally altered inhibito...
_timestamp2019-11-07 19:48:07
created[InstanceEdit:143359] Matthews, L, 2004-11-09 14:12:28
modified[InstanceEdit:143427] Matthews, L, 2004-11-09 23:51:25
[InstanceEdit:9667184] D'Eustachio, Peter, 2019-11-07
textThe mechanism by which the conformationally altered inhibitory form of Mad2 is released from its association with Mad1 at the kinetochore is not known. Mad1 and Cdc20 have a common 10 residue Mad2 binding motif. Therefore, one possibility is that Mad2 is transferred competitively from Mad1 to Cdc20 (Luo et al., 2002; Sironi et al., 2002).
(summation)[Reaction:141439] Release of activated MAD2 from kinetochores [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The mechanism by which the conformationally altered inhibito... (143360)